You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

27 search results for: cytokines

How type 2 <b>cytokines</b> can amplify inflammatory response in CSU
expert video

How type 2 cytokines can amplify inflammatory response in CSU

Dermatology
Dr. Thomos Casale explores the role of Th2 inflammation in CSU, highlighting the impact of IgE autoantibodies and the need for targeted therapies against Th2 cytokines.
View more
Contributions of Type 2 <b>Cytokines</b> to Chronic Pruritus in AD, PN, and CSU
expert video

Contributions of Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU

Dermatology
Dr. Elmariah introduces the multiple roles of type 2 cytokines in chronic itch.
View more
The Role of Mast Cells, Basophils, and Type 2 Cells and <b>Cytokines</b> in CSU
Infographic

The Role of Mast Cells, Basophils, and Type 2 Cells and Cytokines in CSU

Dermatology
The pathophysiology of chronic spontaneous urticaria (CSU) is complex and involves mast cell degranulation and elements of type 2 inflammation. Learn more about the role of mast cells, basophils, and type 2 inflammatory cells and cytokines involved in the pathophysiology of CSU.
View more
Connecting the Dots: Novel Insights on Type 2 <b>Cytokines</b> Mediating Neuroimmune Dysregulation in PN and CSU
expert video

Connecting the Dots: Novel Insights on Type 2 Cytokines Mediating Neuroimmune Dysregulation in PN and CSU

Dermatology
Dr. Kim discusses the roles of type 2 cytokines at the neuroimmune axis In PN and CSU and conveys how neuroimmune interactions give rise to chronic itch and skin lesions in each disease
View more
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
expert video

Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13

Pulmonology
Dr. Reynold Panettieri discusses how IL-4 and IL-13 drive airway remodeling in type 2 asthma.
View more
Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid
expert video

Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid

Dermatology
Join Dr. Victoria Werth in exploring the clinical presentation of BP and how type 2 inflammation contributes to the development of disease signs and symptoms
View more
Inside the Hive: ​Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Inside the Hive: ​Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Dermatology
Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema
View more
The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis
expert video

The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis

Type 2 Inflammation
Join Dr. Shawn Kwatra in discussing the diverse clinical presentations of PN and the role of type 2 inflammation in disease pathogenesis.
View more
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
expert video

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients

Pulmonology
Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.
View more
What Are the Key Inflammatory Processes in Patients with COPD?
expert video

What Are the Key Inflammatory Processes in Patients with COPD?

Pulmonology
Dr. Klaus Rabe, MD, PhD, discusses the key inflammatory processes in patients with COPD and their implications for patient care.
View more
The Cycle of Inflammation in Adult Asthma
interactivity

The Cycle of Inflammation in Adult Asthma

Pulmonology
Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in asthma patients.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region